DRUG/DEVICE

Ralinepag, extended-release tablets, for oral use

ROUTE OF ADMINISTRATION

Oral

THERAPEUTIC PLATFORM

NCE / Novel Biologics

CLINICAL TRIAL

TERRITORY

Worldwide, subject to out-licenses granted in the People’s Republic of China and certain other Asian territories

STATUS

Phase 3

Ralinepag is a development-stage product not approved for sale in any jurisdiction.